These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 17175853)

  • 41. An audit of the assessment and management of adults admitted to Christchurch Hospital with community acquired pneumonia.
    Meyer RJ; Town GI; Harrè E; Koning M; Hurrell M; Beard ME; Chambers ST
    N Z Med J; 1997 Sep; 110(1052):349-52. PubMed ID: 9364175
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improving the implementation of community-acquired pneumonia guidelines.
    Wright AA; Maydom BW
    Intern Med J; 2004 Aug; 34(8):507-9. PubMed ID: 15317551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals.
    Dudas V; Hopefl A; Jacobs R; Guglielmo BJ
    Ann Pharmacother; 2000 Apr; 34(4):446-52. PubMed ID: 10772428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Initial antibiotic management of community acquired pneumonia.
    Astin GT; Honig E; Shipp C; Moore B; McClellan W
    J Med Assoc Ga; 1997 Apr; 86(2):105-8. PubMed ID: 9114656
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Real life management of community-acquired Pneumonia in adults in the Gulf region and comparison with practice guidelines: a prospective study.
    Mahboub B; Al Zaabi A; Al Ali OM; Ahmed R; Niederman MS; El-Bishbishi R
    BMC Pulm Med; 2015 Sep; 15():112. PubMed ID: 26424530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Causes of non-adherence to therapeutic guidelines in severe community-acquired pneumonia.
    Gattarello S; Ramírez S; Almarales JR; Borgatta B; Lagunes L; Encina B; Rello J;
    Rev Bras Ter Intensiva; 2015; 27(1):44-50. PubMed ID: 25909312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of new therapies for severe community-acquired pneumonia.
    Restrepo MI; Anzueto A
    Curr Opin Infect Dis; 2006 Dec; 19(6):557-64. PubMed ID: 17075331
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibiotics for community-acquired pneumonia.
    Dryden M; Hand K; Davey P;
    J Antimicrob Chemother; 2009 Dec; 64(6):1123-5. PubMed ID: 19820250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for moxifloxacin in community-acquired pneumonia: the impact of pharmaco-economic considerations on guidelines.
    Simoens S
    Curr Med Res Opin; 2009 Oct; 25(10):2447-57. PubMed ID: 19678752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Empirical management of community-acquired pneumonia: impact of concurrent A/H1N1 influenza pandemic on guideline implementation.
    Cortoos PJ; Gilissen C; Mol PG; Van den Bossche F; Simoens S; Willems L; Leenaers H; Vandorpe L; Peetermans WE; Laekeman G
    J Antimicrob Chemother; 2011 Dec; 66(12):2864-71. PubMed ID: 21926079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A pharmacist-led prospective antibiotic stewardship intervention improves compliance to community-acquired pneumonia guidelines in 39 public and private hospitals across South Africa.
    van den Bergh D; Messina AP; Goff DA; van Jaarsveld A; Coetzee R; de Wet Y; Bronkhorst E; Brink A; Mendelson M; Richards GA; Feldman C; Schellack N;
    Int J Antimicrob Agents; 2020 Dec; 56(6):106189. PubMed ID: 33045348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The measurement of time to first antibiotic dose for pneumonia in the emergency department: a white paper and position statement prepared for the American Academy of Emergency Medicine.
    Pines JM; Isserman JA; Hinfey PB
    J Emerg Med; 2009 Oct; 37(3):335-40. PubMed ID: 19717266
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Optimizing the antibiotics policy in The Netherlands. VIII. Revised SWAB guidelines for antimicrobial therapy in adults with community-acquired pneumonia].
    Schouten JA; Prins JM; Bonten M; Degener JE; Janknegt R; Hollander JM; Jonkers R; Wijnands W; Verheij T; Sachs A; Kullberg BJ
    Ned Tijdschr Geneeskd; 2005 Nov; 149(45):2495-500. PubMed ID: 16304886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: a qualitative study.
    Schouten JA; Hulscher ME; Natsch S; Kullberg BJ; van der Meer JW; Grol RP
    Qual Saf Health Care; 2007 Apr; 16(2):143-9. PubMed ID: 17403764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identifying barriers to the rapid administration of appropriate antibiotics in community-acquired pneumonia.
    Barlow G; Nathwani D; Myers E; Sullivan F; Stevens N; Duffy R; Davey P
    J Antimicrob Chemother; 2008 Feb; 61(2):442-51. PubMed ID: 18065412
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improving the care of patients with community-acquired pneumonia: a multihospital collaborative QI project.
    Metersky ML; Galusha DH; Meehan TP
    Conn Med; 1999 Jul; 63(7):425-31. PubMed ID: 10461412
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence-based emergency medicine/critically appraised topic. Evidence behind the 4-hour rule for initiation of antibiotic therapy in community-acquired pneumonia.
    Yu KT; Wyer PC
    Ann Emerg Med; 2008 May; 51(5):651-62, 662.e1-2. PubMed ID: 18272253
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
    Charles PG; Whitby M; Fuller AJ; Stirling R; Wright AA; Korman TM; Holmes PW; Christiansen KJ; Waterer GW; Pierce RJ; Mayall BC; Armstrong JG; Catton MG; Nimmo GR; Johnson B; Hooy M; Grayson ML;
    Clin Infect Dis; 2008 May; 46(10):1513-21. PubMed ID: 18419484
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
    Falguera M; Carratalà J; Ruiz-Gonzalez A; Garcia-Vidal C; Gazquez I; Dorca J; Gudiol F; Porcel JM
    Respirology; 2009 Jan; 14(1):105-11. PubMed ID: 18699803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIV infection does not influence clinical outcomes in hospitalized patients with bacterial community-acquired pneumonia: results from the CAPO international cohort study.
    Christensen D; Feldman C; Rossi P; Marrie T; Blasi F; Luna C; Fernandez P; Porras J; Martinez J; Weiss K; Levy G; Lode H; Gross P; File T; Ramirez J;
    Clin Infect Dis; 2005 Aug; 41(4):554-6. PubMed ID: 16028168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.